Inventor · disambiguated record
Jiamin Gu
Also filed as: GU JIAMIN
16 granted patents·12 pending applications·22 citations·filing 2011–2025
90Inventor score
Files withRISEN SUZHOU PHARMA TECH CO LTD24ALLIANTHERA SUZHOU BIOPHARMACEUTICAL CO LTD2SCHMIDT BORIS1SHANGHAI JUNSHI BIOSCIENCES CO LTD1
Top patents by PatentIndex Score
28 records- 0192US11970490B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Apr 30, 2024·4 cites·24 claims
- 0289US11608314B2Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Mar 21, 2023·2 cites·16 claims
- 0389US11225497B2Prodrugs of a CDK inhibitor for treating cancersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Granted Jan 18, 2022·2 cites·16 claims
- 0489US10954188B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Mar 23, 2021·4 cites·17 claims
- 0585US12459888B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2024·Granted Nov 4, 2025·0 cites·3 claims
- 0685US10472323B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2017·Granted Nov 12, 2019·5 cites·20 claims
- 0784US11186543B2Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Nov 30, 2021·2 cites·24 claims
- 0884US2025353870A1Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
- 0982US11530234B2CD73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Granted Dec 20, 2022·1 cites·21 claims
- 1079US12312378B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 1177US2023295079A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
- 1276US10881681B2CD73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Jan 5, 2021·2 cites·21 claims
- 1375US11725020B2Prodrugs of a CDK inhibitor for treating cancersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Aug 15, 2023·0 cites·20 claims
- 1471US2025352516A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular diseaseRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
- 1569US2025109100A1Crystalline form of 3- ((l-valyl) amino) -i-propanesulfonic acidRISEN SUZHOU PHARMA TECH CO LTD·Filed 2024·Application pending·0 cites
- 1669US2021347731A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 1768US12365675B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Jul 22, 2025·0 cites·20 claims
- 1866US12403129B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular diseaseRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Sep 2, 2025·0 cites·2 claims
- 1962US11591358B2Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Feb 28, 2023·0 cites·15 claims
- 2061US2025136556A1Novel modulators of the aryl hydrocarbon receptor and methods of use thereofALLIANTHERA SUZHOU BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2159US2024351988A1Aryl hydrocarbon receptor modulators and their use in the treatment of diseases and disordersALLIANTHERA SUZHOU BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2259US2023019098A1Bivalent compounds, conjugates and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
- 2358US2025333730A1Sirna for inhibiting angptl3 gene expression and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2458US2024279265A1Crystal forms of glucosamine derivative, and preparation method therefor and use thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
- 2555US12338205B2Crystalline form of 3-((L-valyl) amino)-1-propanesulfonic acidRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Jun 24, 2025·0 cites·20 claims
- 2650US2021078970A1Prodrugs of the tyrosine kinase inhibitor for treating cancerRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Application pending·0 cites
- 2743US11718636B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Aug 8, 2023·0 cites·19 claims
- 2829US2013287700A1Compounds for the diagnosis of neurodegenerative disorders on the olfactory epitheliumSCHMIDT BORIS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jiamin Gu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →